Corrigendum to “ A critical sp1 element in the rhesus rhadinovirus (RRV) Rta promoter confers high-level activity that correlates with cellular permissivity for viral replication” (S0042682213005734) (10.1016/j.virol.2013.10.013));A critical Sp1 element in the rhesus rhadinovirus (RRV) Rta promoter confers high-level activity that correlates with cellular permissivity for viral replication

Virology

Volumn 448, Issue , 2014, Pages 196-209

  DeMaster, Laura K ^a,b,d   Rose, Timothy M ^b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

KSHV; Macaque; Promoter; Replication; Rhadinovirus; RRV; Rta; Sp1; Transactivator

Indexed keywords

HOST FACTOR; LATENCY ASSOCIATED NUCLEAR ANTIGEN; TRANSCRIPTION FACTOR SP1;

ARTICLE; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LATENT VIRUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RHADINOVIRUS; RHESUS RHADINOVIRUS; RTA GENE; VIRUS GENE; VIRUS REACTIVATION; VIRUS REPLICATION;

CERCOPITHECINE HERPESVIRUS 17; HUMAN HERPESVIRUS 8; RHADINOVIRUS;

EID: 84887162893     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2017.09.011     Document Type: Erratum

References (74)

1. Alexander L., Denekamp L., Knapp A., Auerbach M.R., Damania B., Desrosiers R.C. The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577. J. Virol. 2000, 74:3388-3398.
2. Barranco S.C., Townsend C.M., Casartelli C., Macik B.G., Burger N.L., Boerwinkle W.R., Gourley W.K. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res. 1983, 43:1703-1709.
3. Bechtel J.T., Winant R.C., Ganem D. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2005, 79:4952-4964.
4. Bellare P., Ganem D. Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 2009, 6:570-575.
5. Bruce A.G., Bakke A.M., Thouless M.E., Rose T.M. Development of a real-time QPCR assay for the detection of RV2 lineage-specific rhadinoviruses in macaques and baboons. Virol. J. 2005, 2:2.
6. Bruce A.G., Bakke A.M., Gravett C.A., DeMaster L.K., Bielefeldt-Ohmann H., Burnside K.L., Rose T.M. The ORF59 DNA polymerase processivity factor homologs of Old World primate RV2 rhadinoviruses are highly conserved nuclear antigens expressed in differentiated epithelium in infected macaques. Virol. J. 2009, 6:205.
7. Bruce A.G., Bielefeldt-Ohmann H., Barcy S., Bakke A.M., Lewis P., Tsai C.C., Murnane R.D., Rose T.M. Macaque homologs of EBV and KSHV show uniquely different associations with simian AIDS-related lymphomas. PLoS Pathog. 2012, 8:e1002962.
8. Bruce, A.G., Ryan, J.T., Thomas, M.J., Peng, X., Grundhoff, A., Tsai, C.-C., Rose, T.M. Next-generation sequence analysis of the genome of RFHVMn, the macaque homolog of KSHV, from a KS-like tumor of a pig-tailed macaque. J. Virol., in press.
9. Burnside K.L., Ryan J.T., Bielefeldt-Ohmann H., Gregory Bruce A., Thouless M.E., Tsai C.C., Rose T.M. RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells. Virology 2006, 354:103-115.
10. Chang P.J., Chen L.W., Shih Y.C., Tsai P.H., Liu A.C., Hung C.H., Liou J.Y., Wang S.S. Role of the cellular transcription factor YY1 in the latent-lytic switch of Kaposi's sarcoma-associated herpesvirus. Virology 2011, 413:194-204.
11. Cohen A., Wolf D.G., Guttman-Yassky E., Sarid R. Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects. Crit. Rev. Clin. Lab. Sci. 2005, 42:101-153.
12. Damania B., Jeong J.H., Bowser B.S., DeWire S.M., Staudt M.R., Dittmer D.P. Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses. J. Virol. 2004, 78:5491-5499.
13. DeWire S.M., Damania B. The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits viral replication through repression of Orf50/Rta transcriptional activation. J. Virol. 2005, 79:3127-3138.
14. DeWire S.M., McVoy M.A., Damania B. Kinetics of expression of rhesus monkey rhadinovirus (RRV) and identification and characterization of a polycistronic transcript encoding the RRV Orf50/Rta, RRV R8, and R8.1 genes. J. Virol. 2002, 76:9819-9831.
15. DeWire S.M., Money E.S., Krall S.P., Damania B. Rhesus monkey rhadinovirus (RRV): construction of a RRV-GFP recombinant virus and development of assays to assess viral replication. Virology 2003, 312:122-134.
16. Desrosiers R.C., Sasseville V.G., Czajak S.C., Zhang X., Mansfield K.G., Kaur A., Johnson R.P., Lackner A.A., Jung J.U. A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J. Virol. 1997, 71:9764-9769.
17. Dittmer D., Lagunoff M., Renne R., Staskus K., Haase A., Ganem D. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 1998, 72:8309-8315.
18. Dittmer D.P., Gonzalez C.M., Vahrson W., DeWire S.M., Hines-Boykin R., Damania B. Whole-genome transcription profiling of rhesus monkey rhadinovirus. J. Virol. 2005, 79:8637-8650.
19. Fojas de Borja P., Collins N.K., Du P., Azizkhan-Clifford J., Mudryj M. Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. Embo J. 2001, 20:5737-5747.
20. Garrigues H.J., Rubinchikova Y.E., Dipersio C.M., Rose T.M. Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptor. J. Virol. 2008, 82:1570-1580.
21. Gelman I.H., Silverstein S. Herpes simplex virus immediate-early promoters are responsive to virus and cell trans-acting factors. J. Virol. 1987, 61:2286-2296.
22. Gradoville L., Gerlach J., Grogan E., Shedd D., Nikiforow S., Metroka C., Miller G. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J. Virol. 2000, 74:6207-6212.
23. Greensill J., Sheldon J.A., Murthy K.K., Bessonette J.S., Beer B.E., Schulz T.F. A chimpanzee rhadinovirus sequence related to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8: increased detection after HIV-1 infection in the absence of disease. AIDS (London, England) 2000, 14:F129-135.
24. Greensill J., Sheldon J.A., Renwick N.M., Beer B.E., Norley S., Goudsmit J., Schulz T.F. Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates?. J. Virol. 2000, 74:1572-1577.
25. Gunther T., Grundhoff A. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 2010, 6:e1000935.
26. Harrison S.M., Whitehouse A. Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHV ORF50 promoter. FEBS Lett. 2008, 582:3080-3084.
27. Hilton I.B., Dittmer D.P. Quantitative analysis of the bidirectional viral G-protein-coupled receptor and lytic latency-associated nuclear antigen promoter of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2012, 86:9683-9695.
28. Katano H., Sata T., Suda T., Nakamura T., Tachikawa N., Nishizumi H., Sakurada S., Hayashi Y., Koike M., Iwamoto A., Kurata T., Mori S. Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma. J. Med. Virol. 1999, 59:346-355.
29. Kim Y.H., Park J.W., Lee J.Y., Kwon T.K. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. Carcinogenesis 2004, 25:1813-1820.
30. Krishnan H.H., Naranatt P.P., Smith M.S., Zeng L., Bloomer C., Chandran B. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 2004, 78:3601-3620.
31. Lacoste V., Mauclere P., Dubreuil G., Lewis J., Georges-Courbot M.C., Gessain A. KSHV-like herpesviruses in chimps and gorillas. Nature 2000, 407:151-152.
32. Lacoste V., Mauclere P., Dubreuil G., Lewis J., Georges-Courbot M.C., Rigoulet J., Petit T., Gessain A. Simian homologues of human gamma-2 and betaherpesviruses in mandrill and drill monkeys. J. Virol. 2000, 74:11993-11999.
33. Lacoste V., Mauclere P., Dubreuil G., Lewis J., Georges-Courbot M.C., Gessain A. A novel gamma 2-herpesvirus of the Rhadinovirus 2 lineage in chimpanzees. Genome Res. 2001, 11:1511-1519.
34. Lan K., Kuppers D.A., Verma S.C., Robertson E.S. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J. Virol. 2004, 78:6585-6594.
35. Lan K., Kuppers D.A., Verma S.C., Sharma N., Murakami M., Robertson E.S. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J. Virol. 2005, 79:7453-7465.
36. Lania L., Majello B., De Luca P. Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol. 1997, 29:1313-1323.
37. Lin S.F., Robinson D.R., Oh J., Jung J.U., Luciw P.A., Kung H.J. Identification of the bZIP and Rta homologues in the genome of rhesus monkey rhadinovirus. Virology 2002, 298:181-188.
38. Lu F., Zhou J., Wiedmer A., Madden K., Yuan Y., Lieberman P.M. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J. Virol. 2003, 77:11425-11435.
39. Lu J., Verma S.C., Cai Q., Robertson E.S. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection. J. Virol. 2011, 85:6148-6161.
40. Lukac D.M., Renne R., Kirshner J.R., Ganem D. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 1998, 252:304-312.
41. Lukac D.M., Kirshner J.R., Ganem D. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 1999, 73:9348-9361.
42. Lukac D.M., Garibyan L., Kirshner J.R., Palmeri D., Ganem D. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters. J. Virol. 2001, 75:6786-6799.
43. Majumdar G., Harmon A., Candelaria R., Martinez-Hernandez A., Raghow R., Solomon S.S. O-glycosylation of Sp1 and transcriptional regulation of the calmodulin gene by insulin and glucagon. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E584-591.
44. Matsumura S., Fujita Y., Gomez E., Tanese N., Wilson A.C. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). J. Virol. 2005, 79:8493-8505.
45. Merchant J.L., Du M., Todisco A. Sp1 phosphorylation by Erk 2 stimulates DNA binding. Biochem. Biophys. Res. Commun. 1999, 254:454-461.
46. Messeguer X., Escudero R., Farre D., Nunez O., Martinez J., Alba M.M. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 2002, 18:333-334.
47. Nagaoka M., Shiraishi Y., Sugiura Y. Selected base sequence outside the target binding site of zinc finger protein Sp1. Nucleic Acids Res. 2001, 29:4920-4929.
48. Nellesen D.T., Lai E.C., Posakony J.W. Discrete enhancer elements mediate selective responsiveness of enhancer of split complex genes to common transcriptional activators. Dev. Biol. 1999, 213:33-53.
49. Omotehara F., Kawamata H., Uchida D., Hino S., Nakashiro K., Fujimori T. Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line. Br. J. Cancer 2002, 87:1042-1046.
50. Pearce M., Matsumura S., Wilson A.C. Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. J. Virol. 2005, 79:14457-14464.
51. Pinto-Santini D.M., Salama N.R. Cag3 is a novel essential component of the Helicobacter pylori Cag type IV secretion system outer membrane subcomplex. J. Bacteriol. 2009, 191:7343-7352.
52. Renne R., Barry C., Dittmer D., Compitello N., Brown P.O., Ganem D. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2001, 75:458-468.
53. Robinson B.A., O'Connor M.A., Li H., Engelmann F., Poland B., Grant R., DeFilippis V., Estep R.D., Axthelm M.K., Messaoudi I., Wong S.W. Viral interferon regulatory factors are critical for delay of the host immune response against rhesus macaque rhadinovirus infection. J. Virol. 2012, 86:2769-2779.
54. Rose T.M., Strand K.B., Schultz E.R., Schaefer G., Rankin G.W., Thouless M.E., Tsai C.C., Bosch M.L. Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. J. Virol. 1997, 71:4138-4144.
55. Sakakibara S., Ueda K., Chen J., Okuno T., Yamanishi K. Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression. J. Virol. 2001, 75:6894-6900.
56. Sarid R., Olsen S.J., Moore P.S. Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology. Adv. Virus Res. 1999, 52:139-232.
57. Sarid R., Wiezorek J.S., Moore P.S., Chang Y. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J. Virol. 1999, 73:1438-1446.
58. Schultz E.R., Rankin G.W., Blanc M.P., Raden B.W., Tsai C.C., Rose T.M. Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi's sarcoma-associated herpesvirus. J. Virol. 2000, 74:4919-4928.
59. Searles R.P., Bergquam E.P., Axthelm M.K., Wong S.W. Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 1999, 73:3040-3053.
60. Shirasuna K., Sato M., Miyazaki T. A neoplastic epithelial duct cell line established from an irradiated human salivary gland. Cancer 1981, 48:745-752.
61. Song M.J., Li X., Brown H.J., Sun R. Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 2002, 76:5000-5013.
62. Speck S.H., Ganem D. Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe 2010, 8:100-115.
63. Sun R., Lin S.F., Gradoville L., Yuan Y., Zhu F., Miller G. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 1998, 95:10866-10871.
64. Talbot S.J., Weiss R.A., Kellam P., Boshoff C. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 1999, 257:84-94.
65. Wang S.E., Wu F.Y., Yu Y., Hayward G.S. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters. J. Virol. 2003, 77:9590-9612.
66. Wang S.E., Wu F.Y., Chen H., Shamay M., Zheng Q., Hayward G.S. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J. Virol. 2004, 78:4248-4267.
67. Wen K.W., Dittmer D.P., Damania B. Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus. J. Virol. 2009, 83:9786-9802.
68. Wilson S.J., Tsao E.H., Webb B.L., Ye H., Dalton-Griffin L., Tsantoulas C., Gale C.V., Du M.Q., Whitehouse A., Kellam P. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency. J. Virol. 2007, 81:13578-13586.
69. Yang J., Kawai Y., Hanson R.W., Arinze I.J. Sodium butyrate induces transcription from the G alpha(i2) gene promoter through multiple Sp1 sites in the promoter and by activating the MEK-ERK signal transduction pathway. J. Biol. Chem. 2001, 276:25742-25752.
70. Yang X., Su K., Roos M.D., Chang Q., Paterson A.J., Kudlow J.E. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. USA 2001, 98:6611-6616.
71. Ye J., Shedd D., Miller G. An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate. J. Virol. 2005, 79:1397-1408.
72. Ye J., Gradoville L., Daigle D., Miller G. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. J. Virol. 2007, 81:9279-9291.
73. Yu F., Feng J., Harada J.N., Chanda S.K., Kenney S.C., Sun R. B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus. FEBS Lett. 2007, 581:3485-3488.
74. Zhang C., Wang Y., Zhou Z., Zhang J., Tian Z. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis. Cancer Immunol. Immunother. 2009, 58:1275-1285.